Metabolic-Fit / 100
VevaRX review
Its own semaglutide page gives two different prices for the same product. The pricing cards read $189 a month or $399 for three months, and the paragraph directly beneath them reads $167 a month or $467 for three — and since $467 is the tirzepatide total, the text appears to be leftover copy from the other product. The tirzepatide page has an arithmetic problem of its own, advertising $467 as equivalent to $149 a month when three months at $467 is $155.67, and there is no monthly tirzepatide plan at all: a three-month minimum applies and the plan renews every three months. The terms then compound it by referring repeatedly to a different company's website and listing prices that match nothing on the product pages. What is genuinely strong is easy to miss underneath all that. VevaRX enumerates thirty-six states by name rather than claiming fifty, it locks the price before intake and holds it at every dose, and the quoted figure includes the provider visit, the supplies and free two-to-three-day shipping.
- HSA / FSA-eligible
- Editor-vetted
- No insurance needed
Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Every clinical figure in this piece is cited inline to its primary source — the trial or the FDA label — so you can open it and check us. This is background reading, not medical advice.
VevaRX at a glance
- Semaglutide
- $189/mo
- Tirzepatide
- $155.67/mo, sold only as a 3-month plan
- Coverage
- 36 states, enumerated
- Brand-name
- Compounded only
How we scored VevaRX
Every factor comes from VevaRX's own published pricing, disclosures and oversight, and the six combine into the 31/100 Metabolic-Fit Score by the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
No postpartum or breastfeeding framing — a generic weight program.
Thin on the hormonal picture that drives many mothers' weight.
Oversight and lab support fall short of the top of this roster — the review below says exactly where.
Cost is unpredictable or sits at the premium end.
Support is thin once the prescription ships.
Exit terms are the weak point: lock-in, notice periods, or a cancellation you have to chase.
How we verified this review
- Last verified
- September 2026
- Confidence
- medium
- Primary source
- vevarx.com
Its own semaglutide page gives two different prices for the same product. The cards say $189 a month or $399 for three months; the paragraph directly beneath them says $167 a month or $467 for three — and $467 is the tirzepatide price, so the text appears to be left over from the other product. The tirzepatide page has its own arithmetic problem: it advertises $467 as equivalent to $149 a month when three months of $467 is $155.67. There is no monthly tirzepatide plan at all, only a three-month minimum that renews every three months. The terms then refer repeatedly to a different company's website. Thirty-six states are listed by name, which is a real strength.
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $189 | Monthly planThe monthly card on the semaglutide page. The prose lower down the SAME page says the monthly program is $167, so the site gives two different monthly prices for one product. |
| Compounded semaglutide | $133 | 3-month plan, one charge of $399Labeled BEST VALUE and "Equivalent to $133/month". The prose below it instead describes a 3-month program at $467, which is the tirzepatide total. |
| Compounded tirzepatide | $156 | 3-month plan, one charge of $467 — the only option⛔ Advertised as "Equivalent to $149 per month", but $467 across three months is $155.67. There is no monthly tirzepatide plan; a three-month minimum applies and it renews every three months. |
Swipe the table to see plan details →
Many HSA and FSA plans cover GLP-1 telehealth — check yours. These figures are what VevaRX's own site disclosed at last review; this market re-prices often, so confirm the current number at the source.
What we like
- Thirty-six states enumerated by name rather than an unverifiable fifty-state claim
- The price is locked in before intake and holds at every dose
- The quoted figure includes the provider visit, supplies and free two-to-three-day shipping
- A monthly semaglutide plan now exists alongside the three-month one
The caveats
- The semaglutide page states two different monthly prices, $189 and $167, for the same product
- It also states two different three-month totals, $399 and $467, one of which is the tirzepatide price
- Tirzepatide is advertised as $149 a month when $467 over three months is $155.67
- There is no monthly tirzepatide option — a three-month minimum applies and renews every three months
- The terms repeatedly reference a different company's website and list prices matching no product page
- No compounding pharmacy is named, and nothing addresses pregnancy, breastfeeding or postpartum timing
VevaRX for mothers: our verdict
Its own semaglutide page gives two different prices for the same product. The pricing cards read $189 a month or $399 for three months, and the paragraph directly beneath them reads $167 a month or $467 for three — and since $467 is the tirzepatide total, the text appears to be leftover copy from the other product. The tirzepatide page has an arithmetic problem of its own, advertising $467 as equivalent to $149 a month when three months at $467 is $155.67, and there is no monthly tirzepatide plan at all: a three-month minimum applies and the plan renews every three months. The terms then compound it by referring repeatedly to a different company's website and listing prices that match nothing on the product pages. What is genuinely strong is easy to miss underneath all that. VevaRX enumerates thirty-six states by name rather than claiming fifty, it locks the price before intake and holds it at every dose, and the quoted figure includes the provider visit, the supplies and free two-to-three-day shipping. It runs about $189/month, flat across every dose.
We weigh VevaRX the way mothers actually have to: not just the monthly cost, but postpartum and breastfeeding timing and PCOS and insulin resistance — the parts a general weight-loss roundup leaves out.
What VevaRX costs, in full
- Compounded semaglutide — Monthly plan: $189/mo
- Compounded semaglutide — 3-month plan, one charge of $399: $133/mo
- Compounded tirzepatide — 3-month plan, one charge of $467 — the only option: $156/mo
That lands within a few dollars of the ~$179/month median across the providers we track, so the monthly cost isn't what should decide this one either way. Weigh it instead on postpartum and breastfeeding timing and PCOS and insulin resistance, and on what the price actually includes — a lower number that leaves out labs, visits or shipping is not the cheaper option.
VevaRX says the price covers the provider visit, the medication and shipping. That is the comparison that matters at this price: two providers a few dollars apart can differ by a hundred a month once the extras are counted, so line up what each one bundles before you decide.
The medications VevaRX prescribes
VevaRX prescribes semaglutide and tirzepatide — the two with the largest published weight-loss effects, and carrying both on one account matters when insulin resistance, common with PCOS and after gestational diabetes, makes tirzepatide the better-suited option. These are compounded formulations from a licensed pharmacy — the reason the price stays down — but compounded GLP-1s aren't FDA-approved finished products the way Wegovy and Zepbound are.
Where VevaRX fits — and where it doesn't — for mothers
A good fit if…
- switching between semaglutide and tirzepatide may become necessary as your body and your hormones change.
Look elsewhere if…
- you specifically want an FDA-approved brand pen with its own pregnancy and lactation labeling.
- you'd rather a prescriber talk through timing around postpartum and breastfeeding timing — that is the ground our #1 pick, CoreAge Rx, is built on.
Oversight, safety, and what we could verify
Our confidence is moderate — the core facts check out, but some details (per-state availability, program mechanics) aren't fully public. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our scoring methodology.
A standing caveat for mothers: GLP-1 medications aren't established as safe during pregnancy or breastfeeding, and every label advises against use. Nothing here changes that — plan the timing with your own clinician.
The bottom line
VevaRX is a reasonable option — weigh it on postpartum and breastfeeding timing and PCOS and insulin resistance against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for mothers
Best for: Someone who wants a price fixed before intake and held at every dose, and who will get the monthly figure confirmed in writing given that the page states two.
Alternatives to VevaRX
Providers we have a referral relationship with, ordered by their Metabolic-Fit Score — highest first. This module leaves out the provider whose page you are reading, so on CoreAge Rx's own review our #1 pick is the one name you will not find here. These are not the whole roster: see the full ranking for every provider we cover, paid or not.
- Visit CoreAge Rx92
Metabolic-Fit / 100
CoreAge RxOur #1 pickOne flat price, both molecules on a single chart, and a prescriber who reads your history before writing — the most predictable place for a mother to start and, just as important, to pause.
- Visit Gala Health84
Metabolic-Fit / 100
A flat $179 for either molecule with a genuinely gentle microdosing tier — a reasonable, all-doses-included option if you can live with a yearly plan and a pharmacy it doesn't name.
- Visit Enhance MD81
Metabolic-Fit / 100
One of the more oversight-forward compounded programs here — lab work and a live provider visit bundled into every plan, with a gentle microdosing tier — the catch is that the low '$212' headline you'll see quoted is the 12-month prepay rate, not the $249 you'd pay month to month.
Keep comparing VevaRX
Head-to-head & alternatives
VevaRX, answered
- What does semaglutide actually cost here?
- The page gives two answers. Its pricing cards say $189 a month or $399 for a three-month plan, and the paragraph immediately below them says $167 a month or $467 for three months. The $467 is the tirzepatide total, so the text looks like leftover copy from the other product. Until VevaRX corrects it, get the figure confirmed in writing before you pay anything.
- Is tirzepatide really $149 a month?
- No. The plan costs $467 for three months, which is $155.67 a month, not the $149 the page advertises beside it. It is a small gap but it is the seller's own arithmetic on its own product page, and there is no monthly option to compare it against — a three-month minimum applies and the plan renews every three months.
- Why do the terms mention another company?
- That is a fair question to put to them. VevaRX's terms and conditions state that transactions are conducted on a different company's website, and they list a set of prices that match nothing on the VevaRX product pages. Legal documents that describe another brand's storefront do not tell you what you are agreeing to.
- What is genuinely good about it?
- Three things. It enumerates thirty-six states by name rather than claiming all fifty, which is a stronger and checkable form of the claim. It states that the price is locked in before intake and holds at every dose, so the bill does not climb as you titrate. And the quoted price includes the provider visit, the supplies and free two-to-three-day shipping rather than adding them later.
Pricing, states and verification reflect VevaRX's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.